Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial.

Publication Year: 2016

DOI:
10.1111/aogs.12877

PMCID:
PMC5021204

PMID:
26915709

Journal Information

Full Title: Acta Obstet Gynecol Scand

Abbreviation: Acta Obstet Gynecol Scand

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gynecology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Dr. von Dadelszen receives consultancy fees and placental growth factor (PlGF) cartridges for research from Alere International. The other authors have stated explicitly that there are no conflicts of interest in connection with this article."

Evidence found in paper:

"Funding CHIPS was funded by the Canadian Institutes of Health Research (MCT 87522)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025